[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Immunity and vaccine optimism", "description": "The Green Book\nhttps://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book\n\nMeasles\n\nhttps://www.who.int/news-room/fact-sheets/detail/measles\n\nDuring 2000- 2018, measles vaccination prevented 23.2 million deaths\n\n73% drop in measles deaths\n\n2018\n\n86% of the world's children received one dose of measles vaccine by their first birthday\n\n140 000 measles deaths globally, children under the age of five\n\nhttps://en.wikipedia.org/wiki/Smallpox\n\nVaccine optimism\n\nhttps://www.inverse.com/science/9-reasons-you-can-be-optimistic-that-a-vaccine-for-covid-19-will-be-widely-available-in-2021\n\nWilliam Petri, Division of Infectious Diseases and International Health, University of Virginia\n\nThe immune system clears the virus in 99% + of infections\n\nhttps://www.psychiatrictimes.com/view/covid-19-has-mortality-rate-declined\n\nSome may have low levels of virus in the body for up to three months\n\nNot normally infectious after day 10\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/end-home-isolation.html\n\nImmune system fails to clear HIV\n\nSARS-CoV-2 doesn\u2019t mutate as HIV does\n\nSARS-CoV-2 needs its spike protein to be infectious\n\nhttps://theconversation.com/what-is-the-ace2-receptor-how-is-it-connected-to-coronavirus-and-why-might-it-be-key-to-treating-covid-19-the-experts-explain-136928\n\nAntibodies have been proved (in vitro) to bind to the spike protein\n\nTherefore neutralizing the spike protein\n\nVaccines in clinical trials, generate spike protein antibodies\n\nhttps://science.sciencemag.org/content/369/6505/806\n\nMonoclonal antibodies could give passive immunity\n\nhttps://science.sciencemag.org/content/369/6505/752\n\nSeven companies developing MABs\n\nCurrently being trial for post exposure protection\n\nMay also be effective for treatment\n\nSpike protein has many locations where antibodies can bind\n\nhttps://science.sciencemag.org/content/369/6504/643\n\nMany vulnerable spots\n\nTherefore, many protein changes in the spike protein would be needed to evade neutralizing antibodies\n\nIf there were to be several sike protein mutations it would no longer bind into the ACE-2 receptor anyway\n\nVaccination science is developed\n\nAntibody-dependent enhancement of infection\n\nAllergic reactions\n\nUse of adjuvants\n\nOperation Warp Speed / Multiple vaccine development\n\nhttps://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html\n\n300 million doses of vaccine by January 2021\n\n$ 8 billion\n\nModerna/NIH, Oxford / AZ, CanSino, Pfizer / Biontech\n\nx 2 to x 4 production of anti-spike neutralizing antibodies\n\nhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext\n\nSafety demonstrated already\n\nPhase 3 trials well underway\n\nhttps://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins\n\nManufacturing underway, stockpile ready for the go\nDistribution logistics already in place", "link": "https://www.youtube.com/watch?v=JZRUq3Igf-k", "date_published": "2020-09-07 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vitamin D, First clinical trial", "description": "https://www.healthline.com/nutrition/how-much-vitamin-d-to-take#How-Common-Is-Vitamin-D-Deficiency\n\nAbout 42% of the US population is vitamin D deficient\n\n82% in black people\n\n70% in Hispanics\n\nAssociation of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results, (JAMA Open, 3rd September, Chicago)\n\nhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770157/meltzer_2020_oi_200688_1598473478.89934.pdf\n\nCohort study of 489\n\nPatients who had a vitamin D level measured in the year before COVID-19\ntesting\n\nRelative risk of testing positive for COVID-19 was 1.77 times\n\nFirst clinical trial on vitamin D and COVID\n\nTherapy versus best Available Therapy on Intensive Care Unit Admission and Mortality Among Patients Hospitalized for COVID-19: A Pilot Randomized Clinical study\" (Spain, Journal of steroid biochemistry and molecular biology)\n\nhttps://www.sciencedirect.com/science/article/pii/S0960076020302764\n\nObjective\n\nVitamin D decreases Acute Respiratory Distress Syndrome\n\nEffect of calcifediol treatment\n\nCalcifediol can rapidly increase serum 25OHD concentration\n\n25-hydroxyvitamin D \n\nIntensive Care Unit Admission and Mortality\n\nSpanish patients hospitalized for COVID-19.\n\nDesign\n\nParallel pilot, randomized, double-masked clinical trial\n\nSetting\n\nReina Sofia University Hospital, C\u00f3rdoba, Spain\n\nParticipants\n\n76 consecutive patients hospitalized with COVID-19 infection\n\nClinical picture of acute respiratory infection\n\nConfirmed by a radiographic pattern of viral pneumonia\n\nPositive SARS-CoV-2 PCR\n\nProcedures\n\nAll hospitalized patients received as best available therapy\n\nHydroxychloroquine and azithromycin \n\nAllocated at a 2 calcifediol:1 \n\nOral calcifediol (0.532\u2009mg), or not\n\nOral calcifediol (0.266\u2009mg) on day 3 and 7\n\nThen weekly until discharge\n\nEnd points, ICU admission and deaths.\n\nResults\n\n50 patients treated with calcifediol\n\nOne required admission to the ICU (2%),\n\nOf 26 untreated patients, 13 required admission (50%)\n\np\u2009 less than 0.001\n\nOf the patients treated with calcifediol, none died, and all were discharged, without complications\n\nOf the patients not treated, 2 died\n\nConclusion\n\nCalcifediol seems to be able to reduce severity of the disease\n\nLarger trials with groups properly matched will be required to show a definitive answer\n\nRationale, activation of the vitamin D receptor (VDR) signalling pathway\n\nReduced ARDS\n\nCytokine/chemokine storm\n\nRegulating the renin angiotensin system\n\nModulating neutrophil activity \n\nMaintaining the integrity of the pulmonary epithelial barrier\n\nStimulating epithelial repair\n\nTapering down the increased coagulability \n\n\nVentilate\n\nDon't abdicate\nDilute that virus \nSo you stay great\nVentilate\nDon't complicate,\nComplain or whine\nYou'll acclimate\nContemplate\nWhen you congregate\nDoes the air here circulate \nInstigate, Nominate\nEducate, Motivate\nI hope this message will resonate\nThat when we populate \nInstead of isolate\nVentilate\nDon't abdicate\nDilute that virus \nSo you stay great", "link": "https://www.youtube.com/watch?v=V8Ks9fUh2k8", "date_published": "2020-09-06 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]